自動体外式除細動器市場- 世界の産業規模、シェア、動向、機会、予測、2018～2028年

自動体外式除細動器の世界市場規模は2022年に32億1,520万米ドルとなり、予測期間のCAGRは2028年まで7.0%と堅調な成長が見込まれています。

除細動器は医療機器として、規則的な心拍を回復させるために心臓に電気ショックやパルスを与えるために利用されます。不整脈として知られる異常な、遅い、または速い心臓リズムを予防または治療するために使用されます。さらに、除細動器は突然拍動が停止した心臓を蘇生させることができます。除細動器にはさまざまなデザインと操作方法があります。自動体外式除細動器（AED）は公共の場で広く利用されており、緊急事態に訓練を受けていない人でも利用できるため、心停止に陥った人を救える可能性があります。その他、装着型除細動器（WCD）や植込み型除細動器（ICD）などの除細動器は、生命を脅かす不整脈のリスクが高い人の突然死を防ぐために使用されます。家庭での除細動器使用に慣れるには時間と労力がかかるため、潜在的な問題に対する認識が重要となります。

主な市場促進要因：

心血管疾患の発生率の増加

患者の生存確率を高める救急心臓医療の進歩にもかかわらず、心血管疾患の蔓延は依然として世界的に重大な死亡原因となっています。調査によると、年間約35万人の米国人が心臓病で死亡しており、その半数は医療施設外で心臓が機能しなくなったときに突然発生します。突然発症するのが特徴の突然の心停止が、こうした早すぎる死の大半を占めています。突然の心停止の引き金となるのは、不規則な心臓のリズム障害である心室細動が一般的です。自動体外式除細動器（AED）は、異常な心臓のリズムを治療するために電気ショックを与える能力によって人気を集めています。これらの装置は、脈のない心室頻拍と心室細動という2つの特定のタイプの心臓不整脈を検出し、治療するように設計されています。今後数年間、AEDの世界市場は、突然の心停止を経験した患者の治療におけるこれらの機器の使用の増加によって、収益を生み出す機会を提示すると予想されます。さらに、喫煙や飲酒に依存する個人の数が増加していることも、市場見通しの繁栄に寄与する可能性があります。

高度除細動器デバイスの採用増加

高度除細動器の採用が大幅に増加しています。これらの最新機器は、ユーザーフレンドリーなインターフェースと自動化機能を備えているため、非専門医を含む幅広い医療専門家が利用しやすくなっています。このアクセシビリティは、緊急事態において、これらの機器を自信を持って操作し、患者ケアと転帰を改善する上で役立っています。先進国でも発展途上国でも医療への支出が増え続ける中、医療機器や技術のアップグレードへの投資が拡大しています。これに伴い、病院や医療施設では、高齢患者特有のニーズに対応し、最適なケアを提供するため、高度な除細動器の導入を優先しています。

質の高い医療に対する需要も高まっています。特に心停止のような危機的状況では、タイムリーな医療介入が極めて重要です。除細動器は、生命を脅かす不整脈への迅速な対応において重要な役割を果たし、蘇生成功の可能性を大幅に高め、患者の転帰を改善します。医療施設、公共スペース、さらには家庭でも除細動器が利用可能で適切に使用されることが、質の高いケア・プロトコルによって優先され、生存率の向上につながります。除細動器は、心臓の正常なリズムを速やかに回復させることで、患者の予後を改善し、長期的な健康影響の軽減に貢献します。このような質の高いケアの重視は、患者の経験と満足度を高めるだけでなく、高度な除細動器技術への投資を促進します。

主な市場動向

次世代除細動器の進歩

除細動器市場は、次世代除細動器の進歩により、当初の予想を上回る加速的な成長が予測されます。除細動器は、機器に関連する問題の特定と解決に重要な役割を果たします。突然の心停止（SCA）は世界の死亡の主要原因であり、致命的な事態を招く可能性があります。しかし、早期介入と除細動により、この状態を効果的に管理することができます。体外式除細動器の中では、自動体外式除細動器（AED）が市場を独占しており、AEDに依存する心不全患者の増加により、市場の大幅な拡大が見込まれています。需要の高まりは、より幅広い種類のAEDが利用可能になったことと一致しています。現在のところ、ウェアラブルは手動式体外式除細動器に対して競合優位を保っています。さらに、今後数年間は皮下植込み型除細動器（S-ICD）、MRI対応植込み型除細動器（ICD）、心臓再同期療法除細動器（CRT-D）が市場成長を後押しすると予想されます。

市場参入企業別投資の増加

技術の進歩と自動体外式除細動器に対する需要の高まりに伴い、市場参入企業はこの分野への投資を一貫して増やしており、今後数年間の分析対象市場の成長予測を後押ししています。MicroPort Scientific Corporationの子会社であるMicroPort Cardiac Rhythm Management Limitedは、植え込み型ペースメーカーと除細動器の開発と商業化、および心臓リズム障害を管理するための関連技術革新に注力しており、2021年7月に1億5,000万米ドルのシリーズC資金調達に関する最終契約を締結しました。市場参入企業によるこのような投資や提携の拡大は、市場拡大の要因となっています。

自動体外式細動市場の主な参入企業は、新製品の創出を促進するために研究開発への投資を強化しています。フィリップスの2020年の年次報告書によると、同社は2018年に17億5,900万ユーロ、2019年に18億8,400万ユーロ、2020年に19億1,500万ユーロの研究開発費を計上しています。このような投資の増加が市場の拡大を後押ししています。

セグメント別洞察

製品タイプ別洞察

製品タイプ別では、世界の除細動器市場は手動式体外式除細動器、完全自動式体外式除細動器（AED）、装着型除細動器に分類されます。2022年にはAED分野が大きな市場シェアを占めています。AEDは、突然の心停止に陥った人を支援するために設計されたポータブル機器です。自動体外式除細動器は、心臓のリズムを分析し、電気ショックまたは除細動を与えて心臓に効果的なリズムを回復させることができる医療機器です。

エンドユーザー別洞察

エンドユーザーセグメントは、病院、プレ病院、公共アクセス市場、代替医療市場、家庭に分類されます。病院セグメントは、病院で治療を受ける心臓病患者の頻度が高く、医療施設で実施される処置が普及していることから、市場で圧倒的な存在感を示すと予測されています。病院では、突然の心停止を経験した患者の治療やその他の医療目的のために、ICDや体外式除細動器がより頻繁に使用されています。2021年1月現在、ボストン・サイエンティフィック社は全世界で約65万9,000台のICDを販売していると報告しています。これは、2020年1月までのICD販売台数60万台に比べ5万9千台と大幅に増加しており、市場の旺盛な需要を示しています。

地域別洞察

2022年の売上高シェアは北米が最も高く、最大の貢献国となっています。主要参入企業の存在感が大きいこと、公共アクセスAEDの可用性を高めるための支援的な規制があること、医療施設での体外式除細動器の普及がこの優位性に寄与しています。特に米国では、米国心臓協会（AHA）などの著名な団体が包括的な公共アクセス除細動（PAD）プログラムの実施を提唱しています。これらのプログラムでは、AEDの戦略的配置、定期的なメンテナンスと検査、対応者の訓練、EMSの調整、継続的な品質改善が重視されています。

一方、体外式除細動器市場は今後数年間、欧州が最も急速に成長すると予測されています。これは、医療のインフラが確立していること、心血管イベントの影響を受けやすい高齢者人口が多いこと、主要な業界参入企業が存在することなどに起因しています。その代表例が、WEINMANN Emergency Medical Technology GmbH+Co.KGは、蘇生と患者モニタリング用に設計された体外式除細動器MEDUCORE Standardシリーズで有名なドイツのメーカーです。これらの装置は、救急医療サービス要員、軍医隊、病院での使用を目的としています。

主要市場参入企業

• Koninklijke Philips N.V.
• Stryker
• Zoll Medical Corporation
• Nihon Kohden Corporation
• ProgettiSrl
• Schiller AG
• MS Westfalia GmbH
• Bexen Cardio
• Silverline Meditech Pvt. Ltd.
• Mediana Co., Ltd.

カスタマイズ

Tech Sci Research社の自動体外式除細動器の世界市場レポートは、与えられた市場データをもとに、企業固有のニーズに合わせたカスタマイズを提供します。レポートでは以下のカスタマイズが可能です。

企業情報

• 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 自動体外式除細動器の世界市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品タイプ別（手動式体外式除細動器、完全自動式体外式除細動器、装着型除細動器）
  • エンドユーザー別（病院、プレ病院、公共アクセス市場、代替医療市場、家庭）
  • 地域別
  • 企業別（2022年）
• 市場マップ

第6章 北米の自動体外式除細動器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の自動体外式除細動器市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
  • エンドユーザー別
  • 国別
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋の自動体外式除細動器市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
  • エンドユーザー別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の自動体外式除細動器市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの自動体外式除細動器市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品タイプ別
  • エンドユーザー別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 製品上市
• 合併と買収
• 最近の動向

第13章 自動体外式除細動器の世界市場のSWOT分析

第14章 競合情勢

• Koninklijke Philips N.V.
• Stryker
• Zoll Medical Corporation
• Nihon Kohden Corporation
• ProgettiSrl
• Schiller AG
• MS Westfalia GmbH
• Bexen Cardio
• Silverline Meditech Pvt. Ltd.
• Mediana Co., Ltd.

第15章 戦略的提言

第16章 調査会社・免責事項

The Global Automated External Defibrillator Market was valued at USD 3,215.2 million in 2022 and is expected to exhibit robust growth in the forecast period, with a CAGR of 7.0% through 2028. Defibrillators, as medical devices, are utilized to administer electric shocks or pulses to the heart in order to restore a regular heartbeat. They are employed to prevent or treat abnormal, slow, or fast heart rhythms known as arrhythmias. Additionally, defibrillators can revive a heart that has suddenly ceased beating. Various designs and operational methods exist for defibrillators. Automated external defibrillators (AEDs) are widely accessible in public places and can be utilized by untrained individuals in emergency situations, potentially saving someone experiencing cardiac arrest. Other types of defibrillators, such as wearable cardioverter defibrillators (WCDs) and implanted cardioverter defibrillators (ICDs), are employed to prevent sudden death in individuals at high risk of life-threatening arrhythmias. Adjusting to having a defibrillator at home may require time and effort, making awareness of potential issues crucial.

Key Market Drivers:

Growing Incidence of Cardiovascular Diseases

The prevalence of cardiovascular diseases remains a significant cause of mortality globally, despite advancements in emergency cardiac care that enhance a patient's chances of survival. Research indicates that approximately 350,000 Americans succumb to heart disease annually, with half of these fatalities occurring unexpectedly outside of medical facilities when the heart ceases to function. Sudden cardiac arrest, characterized by its abrupt onset, accounts for the majority of these untimely deaths. Ventricular fibrillation, an irregular heart rhythm disorder, is typically responsible for triggering sudden cardiac arrest. The automated external defibrillator (AED) is gaining popularity due to its ability to administer electric shocks for treating abnormal heart rhythms. These devices are designed to detect and treat two specific types of cardiac arrhythmias: pulseless ventricular tachycardia and ventricular fibrillation. In the coming years, the global market for AEDs is expected to present revenue-generating opportunities, driven by the increasing use of these devices in treating patients experiencing sudden cardiac arrest. Furthermore, the growing number of individuals dependent on smoking and alcohol consumption could contribute to prosperous market prospects.

Increase in Adoption of Advanced Defibrillator Devices

The adoption of advanced defibrillator devices has seen a significant increase. These modern devices are equipped with user-friendly interfaces and automated features, making them accessible to a wider range of healthcare professionals, including non-specialists. This accessibility has been instrumental in emergency situations, where these devices are confidently operated, improving patient care and outcomes. As healthcare spending continues to rise, both in developed and developing countries, there is a growing investment in upgrading medical equipment and technologies. In line with this, hospitals and healthcare facilities are prioritizing the implementation of advanced defibrillators to meet the unique needs of older patients and provide optimal care.

The demand for quality medical care has also been on the rise. Timely medical interventions are crucial, especially in critical situations like cardiac arrest. Defibrillators play a vital role in rapid response to life-threatening arrhythmias, significantly improving the chances of successful resuscitation and better patient outcomes. The availability and proper use of defibrillators in healthcare facilities, public spaces, and even homes are prioritized through quality care protocols, leading to higher survival rates. By promptly restoring normal heart rhythms, defibrillators contribute to better patient outcomes and reduced long-term health consequences. This focus on quality care not only enhances patient experience and satisfaction but also drives investments in advanced defibrillator technologies.

Technological advancements in healthcare have paved the way for the development of comprehensive end-to-end solutions in the defibrillator market. Favorable government initiatives, coupled with high healthcare expenditures, have created an environment conducive to innovation. Market participants are actively engaged in integrating innovative hardware and sophisticated software, expanding the scope of pre-hospital care for first responders. Notably, companies like Royal Philips have introduced remote monitoring and defibrillator solutions that enable real-time data transfer, revolutionizing pre-hospital care. Startups also play a significant role in driving market growth through their contributions to the defibrillator industry.

However, the market still faces challenges, including accessibility issues with external defibrillators. Studies have shown that the likelihood of an automated external defibrillator (AED) being nearby during a cardiac arrest is low, and there may be further restrictions on access due to closed buildings. Out-of-hospital cardiac arrest remains a significant cause of fatalities, with low survival rates. The limited use of AEDs in public settings can be attributed to concerns about legal liability, training requirements, limited access, and lack of general awareness. Nonetheless, research has unequivocally demonstrated that immediate access to an AED significantly enhances survival chances.

Strict rules and regulations also pose challenges to the defibrillator market. However, with ongoing advancements and initiatives, the industry continues to progress, aiming to overcome these obstacles and improve healthcare outcomes for patients.

Regulatory authorities established by governments worldwide enforce rigorous regulations and policies to govern the automated external defibrillators market. These measures ensure the accessibility of safe, appropriate, and affordable devices that serve their medical purpose for the public. However, these regulations can present challenges for vendors, resulting in delayed approvals and occasional product recalls that incur significant costs.

The licensing, evaluation, surveillance, and control of medical devices have become increasingly intricate for national regulatory authorities. The growing number of new products, quality concerns, and technical issues arising from rapid scientific advancements pose significant hurdles. Consequently, governments are implementing even more stringent regulations, further impacting market growth.

Key Market Trends

Advancements in Next-Generation Defibrillators

The defibrillator market is projected to experience accelerated growth, surpassing initial expectations, owing to advancements in next-generation defibrillators. Defibrillators play a crucial role in identifying and resolving device-related issues. Sudden Cardiac Arrest (SCA), a leading cause of global mortality, carries potential fatality. However, early intervention and defibrillation can effectively manage this condition. Among external defibrillators, Automated External Defibrillators (AEDs) dominate the market and are expected to witness significant expansion, driven by the increasing number of heart failure patients relying on them. The growing demand aligns with the availability of a wider range of AEDs. Currently, wearables hold a competitive edge over manual external defibrillators. Furthermore, market growth is anticipated to receive a boost from Subcutaneous Implantable Cardioverter-Defibrillators (S-ICDs), MRI-compatible Implantable Cardioverter-Defibrillators (ICDs), and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) in the upcoming years.

Increase in Investments by Market Players

With the advancement of technology and the growing demand for automated external defibrillators, market participants are consistently increasing their investment in the field, propelling the projected growth of the analyzed market in the coming years. MicroPort Cardiac Rhythm Management Limited, a subsidiary of MicroPort Scientific Corporation focused on the development and commercialization of implantable pacemaker and defibrillator equipment, along with associated innovations to manage cardiac rhythm disorders, entered into definitive agreements in July 2021 regarding its USD 150 million Series C financing. Such escalating investment and collaborations by market participants serve as drivers for the expansion of the market.

The key players in the automatic external fibrillation market are intensifying their investment in research and development to foster the creation of new products. According to Philips' annual report for 2020, the company incurred research and development expenses amounting to EUR 1,759 million in 2018, EUR 1,884 million in 2019, and EUR 1,915 million in 2020. This increasing investment fuels the expansion of the market.

Segmental Insights

Product Type Insights:

In terms of product type, the global defibrillator market is categorized into Manual External Defibrillator, Fully Automated External Defibrillator (AED), Wearable Cardioverter Defibrillator. The AED segment holds a significant market share in 2022. AEDs are portable devices designed to assist individuals in sudden cardiac arrest. An automated external defibrillator is a medical device capable of analyzing the heart's rhythm and delivering an electrical shock or defibrillation to restore an effective rhythm to the heart.

End User Insights

The end user segment is categorized into Hospitals, Pre-Hospitals, Public Access Market, Alternate Care Market, and Home. The Hospitals segment is projected to have a dominant presence in the market due to the higher frequency of cardiac patients receiving care in hospitals and the prevalence of procedures carried out in healthcare facilities. Hospitals employ ICDs and external defibrillators more frequently for the treatment of patients who have experienced sudden cardiac arrest and for other medical purposes. As of January 2021, Boston Scientific reported a worldwide distribution of approximately 659,000 ICDs. This represents a significant increase of 59,000 compared to the 600,000 ICDs distributed by January 2020, indicating a strong demand in the market.

Regional Insights:

North America accounted for the highest revenue share in 2022, making it the largest contributor. The significant presence of key players, supportive regulations to enhance the availability of public access AEDs, and the widespread adoption of external defibrillators in healthcare facilities contribute to this dominance. Notably, esteemed organizations like the American Heart Association (AHA) in the U.S. advocate for the implementation of comprehensive Public Access Defibrillation (PAD) programs. These programs emphasize strategic placement of AEDs, regular maintenance and testing, responder training, EMS coordination, and continuous quality improvement.

In contrast, Europe is projected to experience the fastest growth in the external defibrillators market in the coming years. This can be attributed to the well-established healthcare infrastructure, a sizable geriatric population susceptible to cardiovascular events, and the presence of key industry players. A prime example is WEINMANN Emergency Medical Technology GmbH + Co. KG, a German manufacturer renowned for its MEDUCORE Standard series of external defibrillators designed for resuscitation and patient monitoring. These devices are intended for use by emergency medical services personnel, military medical corps, and hospitals.

Key Market Players

• Koninklijke Philips N.V.
• Stryker
• Zoll Medical Corporation
• Nihon Kohden Corporation
• ProgettiSrl
• Schiller AG
• MS Westfalia GmbH
• Bexen Cardio
• Silverline Meditech Pvt. Ltd.
• Mediana Co., Ltd.

Report Scope:

In this report, the Global Automated External Defibrillator Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Automated External Defibrillator Market, By Product Type:

• Manual External Defibrillator
• Fully Automated External Defibrillator
• Wearable Cardioverter Defibrillator

Automated External Defibrillator Market, By End User:

• Hospitals
• Pre-Hospitals
• Public Access Market
• Alternate Care Market
• Home

Automated External Defibrillator Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Automated External Defibrillator Market.

Available Customizations:

Global Automated External Defibrillator Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Automated External Defibrillator Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Manual External Defibrillator, Fully Automated External Defibrillator, Wearable Cardioverter Defibrillator)
  • 5.2.2. By End User (Hospitals, Pre-Hospitals, Public Access Market, Alternate Care Market, Home)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Market Map

6. North America Automated External Defibrillator Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Automated External Defibrillator Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Automated External Defibrillator Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Automated External Defibrillator Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By End User

7. Europe Automated External Defibrillator Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Automated External Defibrillator Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Automated External Defibrillator Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Italy Automated External Defibrillator Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By End User
  • 7.3.4. France Automated External Defibrillator Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Automated External Defibrillator Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific Automated External Defibrillator Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Automated External Defibrillator Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Automated External Defibrillator Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Automated External Defibrillator Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Automated External Defibrillator Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Automated External Defibrillator Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By End User

9. South America Automated External Defibrillator Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Automated External Defibrillator Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Automated External Defibrillator Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Automated External Defibrillator Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Automated External Defibrillator Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Automated External Defibrillator Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Automated External Defibrillator Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Automated External Defibrillator Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Product Launches
• 12.2. Mergers & Acquisitions
• 12.3. Recent Developments

13. Global Automated External Defibrillator Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Business Overview
• 14.2. Application Offerings
• 14.3. Recent Developments
• 14.4. Key Personnel
• 14.5. SWOT Analysis
  • 14.5.1. Koninklijke Philips N.V.
  • 14.5.2. Stryker
  • 14.5.3. Zoll Medical Corporation
  • 14.5.4. Nihon Kohden Corporation
  • 14.5.5. ProgettiSrl
  • 14.5.6. Schiller AG
  • 14.5.7. MS Westfalia GmbH
  • 14.5.8. Bexen Cardio
  • 14.5.9. Silverline Meditech Pvt. Ltd.
  • 14.5.10. Mediana Co., Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer